The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.

by Stein, R. C., Dowsett, M., Hedley, A., Gazet, J. C., Ford, H. T., Coombes, R. C.
Published 1990

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies

by Wason, J, Marshall, A, Dunn, J, Stein, R C, Stallard, N
Published 2014

Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study.

by Stein, R. C., Dowsett, M., Cunningham, D. C., Davenport, J., Ford, H. T., Gazet, J. C., von Angerer, E., Coombes, R. C.
Published 1990

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]

by Stein, R. C., Malkovska, V., Morgan, S., Galazka, A., Aniszewski, C., Roy, S. E., Shearer, R. J., Marsden, R. A., Bevan, D., Gordon-Smith, E. C.
Published 1991